temozolomide has been researched along with bal101553 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bachmann, F; Dietrich, PY; Espinoza, FI; Genoud, V; Lane, HA; Marinari, E; McSheehy, P; Rochemont, V; Walker, PR | 1 |
1 other study(ies) available for temozolomide and bal101553
Article | Year |
---|---|
Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin).
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Brain Neoplasms; CD40 Antigens; Cell Line, Tumor; Cell Proliferation; CTLA-4 Antigen; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression; Glioblastoma; HMGB1 Protein; Immune Checkpoint Inhibitors; Interferon-gamma; Mice; Mitosis; Neoplasm Transplantation; Oxadiazoles; Programmed Cell Death 1 Receptor; Survival Rate; Temozolomide; Tumor Microenvironment | 2021 |